As I thought about it, I realized there were three scenarios:
1. Biologx is unrelated to SSOF, since Zimm and Bland have rescinded the deal and SSOF is now a shell again.
2. They are using SSOF to take Biologx publicly trading, and will kick current shareholders to the curb via reverse split.
3. They are trying to make Biologx look valuable, so that if/when they merge it into SSOF it will prop up the PPS of SSOF.
An SSOF long would win (at least getting a temporary bump or blast up) if the truth is #3. If #1, then things could be good eventually, but there will be an initial hit. If #2, then potential catastrophe.
I have no crystal ball, but have seen lots of mergers and have watched Bland and Morris for many years.
I am obviously NOT an investment advisor.